Management

Nitin Sood

Chief Executive Officer


Nitin joined Boreal in June 2011 as Chief Executive Officer and brings an exceptional record of leadership and experience in the Life Sciences industry.

Previously, Nitin served as General Manager of the Automation and separately the Electrophoresis business units at Agilent Technologies where he led a global organization responsible for R&D, marketing, sales, support, and manufacturing functions for a portfolio of instruments and consumables based products. Under Nitin’s leadership, the businesses demonstrated substantial growth by launching new products for life science applications in Genomics, drug discovery and protein analysis. Prior to Agilent, Nitin led the R&D efforts for Applied Biosystem’s informatics business where he lead a team of engineers developing products targeted towards pharmaceutical QA/QC, forensics and chemical markets.

Nitin holds master’s degrees in both computer science and molecular biology.

He can be reached at nsood@borealgenomics.com

Andre Marziali, Ph.D.

Founder, President and Chief Scientific Officer


A leading innovator, educator, and entrepreneur with over 15 years’ experience in developing tools for life science research and technologies for nucleic acid analysis, Andre founded Boreal Genomics with colleagues from the University of British Columbia in 2007.

Andre received his B.A.Sc. in Engineering Physics from UBC in 1989, and his Ph.D. in Physics from Stanford University in 1994. He subsequently worked for several years with Dr. Ron Davis, in the Stanford DNA Sequencing Technology Center, developing instruments for DNA sequencing and sample purification. He returned to Canada in 1998, as an Assistant Professor at University of British Columbia in the Department of Physics and Astronomy, where he founded the Applied Biophysics Laboratory and the Genome BC Technology Development Platform. In 2005 he was appointed Director of the Engineering Physics program at UBC.

In 2004, Andre co-invented the concept of using synchronous mobility perturbations to create divergent velocity fields for selective focusing of nucleic acids, the technology which forms the basis for Boreal’s platform. He has been awarded the 2004 BC Innovation Council – Young Innovator award, the 2007 Association for Lab Automation Innovation Award, and the 2011 Life Science BC Award for Innovation and Achievement.

Comments are closed.